Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer
Industrial Technology
Healthcare
Software
Energy
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
24 Mar 2026
SuperReturn of the Carlsquare x Gain Bar
Events
18 Mar 2026
Equity Research, White Pearl Technology Group: Revenue surging 37%, yet a 60% peer discount defies logic
Equity Research
White Pearl Technology Group
17 Mar 2026
Carlsquare SaaSalon Berlin
Events
16 Mar 2026
French & European Cleantech M&A and Valuations
Insights
12 Mar 2026
Carlsquare welcomes Maurice Harbison as Partner – strengthening Software, FinTech & Digital Services coverage
Company News
12 Mar 2026
Carlsquare advised XPLN's shareholders on the sale of XPLN to Similarweb
Deal News
05 Mar 2026
DMEA 2026 Warm-up
Events
04 Mar 2026
Carlsquare acted as the exclusive debt advisor of enua Pharma on the structuring of a growth financing package
Deal News
02 Mar 2026
Carlsquare advised Aspria on the sale to David Lloyd Leisure, a portfolio company of TDR Capital
Deal News
02 Mar 2026
Equity Research ALM Equity Q4 2025: Higher profit with a thousand housing starts per year
Equity Research
ALM Equity
01 Mar 2026
Equity research Enrad, Q4 2025: A Sweden push to accelerate growth
Equity Research
Enrad
27 Feb 2026
Equity research Enrad, Q4 2025: Soft sales but order pipeline intact
Equity Research
Enrad
27 Feb 2026
Equity research Zinzino Q4 2025: Healthy scalability
Equity Research
Zinzino
26 Feb 2026
Equity Research ALM Equity, Q4 2025: Increased cash and improved prospects
Equity Research
ALM Equity
25 Feb 2026
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
Equity Research
Immunovia
25 Feb 2026
Equity research Zinzino Q4 2024: First impression - Margins significantly above our expectations
Equity Research
Zinzino
24 Feb 2026
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
Equity Research
Immunovia
22 Feb 2026
Equity research Enrad, Q4 2025: A profit for the quarter may be on the cards
Equity Research
Enrad
20 Feb 2026
Equity research Viva Wine Group Q4 2025: Delta profit surprise raises spirits
Equity Research
Viva Wine Group
20 Feb 2026
Equity research Angler Gaming, Q4 2025: A year defined by margin improvement
Equity Research
Angler Gaming
1
2
3
4
5
…
100